See LEGEND for key to shading and symbols.
Subject Area - BIOC Term - Term 2 2019
| BIOC2101 | BIOC2181 | BIOC3111 | BIOC3271 | BIOC3671 | BIOC8608 |
| BIOC8618 |
Data is correct as at Mon Apr 22 18:01:02 AEST 2019
| Comp | Sect | Class | Type | Status | Enr/Cap | % Full | Times (weeks, Location) - default 1hour |
| BIOC2101 | Principles of Biochem (Adv) | ||||||
| CRS | CR01 | 1965 | Open | 39/49 | 80% | (Course Enrolment) | |
| LAB | T10A | 4068 | Enr | Open | 57/60 | 95% | Tue 10-13 (w2-10, Wurth 122) |
| LAB | T10B | 4069 | Enr | Open | 51/60 | 85% | Tue 10-13 (w2-10, Wurth 123) |
| LAB | T14A | 4070 | Enr | Full | 60/60 | 100% | Tue 14-17 (w2-10, Wurth 122) |
| LAB | T14B | 4071 | Enr | Open | 37/60 | 62% | Tue 14-17 (w2-10, Wurth 123) |
| LAB | W10A | 4072 | Enr | Full | 60/60 | 100% | Wed 10-13 (w2-10, Wurth 122) |
| LAB | W10B | 4073 | Enr | Open | 46/60 | 77% | Wed 10-13 (w2-10, Wurth 123) |
| LEC | A | 4067 | Rel | Open | 311/400 | 78% | Mon 15 (w1,3-11, CLB 7); Wed 17 (w1-10, Science Th); Fri 14 (w1-10, MathewsThA) |
| BIOC2181 | Fundamentals of Biochemistry | ||||||
| CRS | CR01 | 2100 | Full | 30/30 | 100% | (Course Enrolment) | |
| LAB | H10A | 4075 | Enr | Full | 58/58 | 100% | Thu 10-13 (w1-10, Wurth 122) |
| LAB | H10B | 4076 | Enr | Open | 43/58 | 74% | Thu 10-13 (w1-10, Wurth 123) |
| LAB | H14A | 4077 | Enr | Full | 58/58 | 100% | Thu 14-17 (w1-10, Wurth 122) |
| LAB | H14B | 4078 | Enr | Open | 42/58 | 72% | Thu 14-17 (w1-10, Wurth 123) |
| LEC | A | 4074 | Rel | Open | 201/231 | 87% | Mon 10 (w1,3-11, CLB 8); Thu 17 (w1-10, MathewsThB); Fri 13 (w1-10, CLB 8) |
| BIOC3111 | Molecular Biology of Proteins | ||||||
| CRS | CR01 | 1827 | Open | 4/30 | 13% | (Course Enrolment) | |
| LAB | M14A | 4080 | Enr | Open | 20/50 | 40% | Mon 14-18 (w1,3-10, TchLab 11) |
| LEC | A | 4079 | Rel | Open | 20/50 | 40% | Mon 12 (w1,3-9,11, BUS 115); Tue 11 (w1-9, PioneerTh); Fri 09 (w1-9, BUS 115) |
| BIOC3271 | Molecular Cell Biology 2 | ||||||
| CRS | CR01 | 2131 | Open | 3/31 | 10% | (Course Enrolment) | |
| LAB | A | 4081 | Enr | Open | 14/45 | 31% | Fri 14-18 (w2-10, TchLab 12) Comb/w BIOC3671 |
| LEC | B | 4082 | Rel | Open | 14/45 | 31% | Mon 10 (w1,3-9,11, CLB 2); Tue 12 (w1-9, CLB 8); Wed 13 (w1-9, CLB 1) Comb/w BIOC3671 |
| BIOC3671 | Molecular Cell Biology 2 (Adv) | ||||||
| CRS | CR01 | 2215 | Open | 0/5 | 0% | (Course Enrolment) | |
| LAB | A | 5962 | Enr | Open | 14/19 | 74% | Fri 14-18 (w2-10, TchLab 12) Comb/w BIOC3271 |
| LEC | B | 5963 | Rel | Open | 14/19 | 74% | Mon 10 (w1,3-9,11, CLB 2); Tue 12 (w1-9, CLB 8); Wed 13 (w1-9, CLB 1) Comb/w BIOC3271 |
| BIOC8608 | (F/T) Biochem Research Thesis | ||||||
| CRS | CR01 | 3491 | Open* | 0/21 | 0% | (Course Enrolment) | |
| THE | 0001 | 3511 | Enr | Open | 29/50 | 58% | |
| BIOC8618 | (P/T)Research Thesis Biochem | ||||||
| CRS | CR01 | 3490 | Open* | 0/1 | 0% | (Course Enrolment) | |
| THE | 0001 | 3512 | Enr | Open | 4/5 | 80% | |
| ^ top ^ | |||||||
| LEGEND | |||||||
| * This class requires consent. Students cannot self-enrol. | |||||||
| # Timetable clash allowed. | |||||||
| /odd Runs in odd weeks only. /even Runs in even weeks only. | |||||||
| Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity. | |||||||
| Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes. | |||||||
| [ ] Class capacity where different from effective capacity. | |||||||
| Shaded cells: | LEC | Activity different from previous | |||||
| Stop | Status is Stop Further Enrolment, Tentative, Closed or Cancelled | ||||||
| 100% | Class is full (> 100% means capacity is exceeded) | ||||||
| 80% | Class is nearly full (80% or more) | ||||||
| 50% | Class is half full | ||||||
| 0% | Class is less than half full | ||||||
| UNSW Sydney NSW 2052, Australia Telephone: (within Aust.) 02 9385 1000, (International) +61 2 9385 1000 CRICOS Provider Code 00098G ABN: 57 195 873 179 Authorised by Vice-President and Deputy Vice-Chancellor (Academic) Privacy Policy Copyright & Disclaimer Accessibility |